Search

This study assessed whether scheduling (start time and day type) and workload variables influenced sleep markers (activity monitor) in professional academy footballers (n=11; 17.3±0.7 yrs) over a 10-week in-season period. Separate linear mixed regressions were used to describe the effect of start time on the previous nights sleep, and the effect of day type (match day, match day+1) and workload on subsequent sleep. Workload variables were modelled by day (day), 7-day (acute), and 28-day (chronic) periods. Sleep duration following match day+1 (400 mins; 95%CI:368-432) was significantly reduced compared to all other day types (p<0.001). Sleep onset time following match day (00:35; CI:00:04-01:12) and wake time on match day+1 (09:00; CI:08:37-09:23) were also significantly later compared to all other day types (p<0.001). Sleep duration (19.1 mins; CI:9.4-28.79), wake time (18 mins; CI:9.3-26.6), and time in bed (16.8 mins; CI:2.0-31.5) were significantly increased per hour delay in start time. When no activity was scheduled, sleep duration (37 mins; CI:18.1-55.9), sleep onset (42.1 mins; CI:28.8-56.2), and wake times (86 mins; CI:72-100) were significantly extended, relative to a 09:00 start time. Day, acute, and chronic workloads were associated with sleep onset and wake times only. Scheduled start times were associated with changes in sleep duration. Therefore, delaying start times may increase sleep in this population., Competing Interests: The authors declare that they have no conflict of interest., (Thieme. All rights reserved.)

This case study reports on a professional football player (age: 17.6 years) who was referred for sleep monitoring and intervention after reporting excessive night-time awakenings. The player undertook a series of subjective sleep assessments and objective sleep monitoring (activity monitor). Based on the data presented, a sleep hygiene intervention was prescribed. Numerical comparisons were made between pre-intervention (Pre) and post-intervention (Post) values. Objective values were also compared to reference data from a similarly aged professional cohort from the same club ( n  = 11). Wake episodes per night (Pre: 7.9 ± 3, Post: 4.5 ± 1.9; -43%) and wake after sleep onset (WASO; Pre: 74.3 ± 31.8 mins, Post: 50.0 ± 22.8 mins, -33%) were improved from Pre to Post. Compared to the reference data, mean wake episodes per night (Pre: 7.9 ± 3.0, reference: 4.6 ± 2.6; -42%) and WASO (Pre: 74.3 ± 31.8 mins, reference: 44.3 ± 36.5 mins; -40%) were all lower compared to Pre levels. Whilst causality cannot be proven, we observed multiple sleep metrics improving following an intervention. This provides a potential framework for practitioners looking to provide targeted sleep assessment and intervention.

This study demonstrates the use of isotopic labelling and NMR to study the HDO process. As far as we know, this is the first reported effort to trace the incorporation of hydrogen in the HDO process of lignin pyrolysis oil thereby providing key fundamental insight into its reaction mechanism.

After allogeneic stem cell transplantation, the establishment of the donor's immune system in an antigenically distinct recipient confers a therapeutic graft-versus-malignancy effect, but also causes graft-versus-host disease (GVHD) and protracted immune dysfunction. In the last decade, a molecular-level description of alloimmune interactions and the process of immune recovery leading to tolerance has emerged. Here, new developments in understanding alloresponses, genetic factors that modify them, and strategies to control immune reconstitution are described. In Section I, Dr. John Barrett and colleagues describe the cellular and molecular basis of the alloresponse and the mechanisms underlying the three major outcomes of engraftment, GVHD and the graft-versus-leukemia (GVL) effect. Increasing knowledge of leukemia-restricted antigens suggests ways to separate GVHD and GVL. Recent findings highlight a central role of hematopoietic-derived antigen-presenting cells in the initiation of GVHD and distinct properties of natural killer (NK) cell alloreactivity in engraftment and GVL that are of therapeutic importance. Finally, a detailed map of cellular immune recovery post-transplant is emerging which highlights the importance of post-thymic lymphocytes in determining outcome in the critical first few months following stem cell transplantation. Factors that modify immune reconstitution include immunosuppression, GVHD, the cytokine milieu and poorly-defined homeostatic mechanisms which encourage irregular T cell expansions driven by immunodominant T cell-antigen interactions. In Section II, Prof. Anne Dickinson and colleagues describe genetic polymorphisms outside the human leukocyte antigen (HLA) system that determine the nature of immune reconstitution after allogeneic stem cell transplantation (SCT) and thereby affect transplant outcomethrough GVHD, GVL, and transplant-related mortality. Polymorphisms in cytokine gene promotors and other less characterized genes affect the cytokine milieu of the recipient and the immune reactivity of the donor. Some cytokine gene polymorphisms are significantly associated with transplant outcome. Other non-HLA genes strongly affecting alloresponses code for minor histocompatibility antigens (mHA). Differences between donor and recipient mHA cause GVHD or GVL reactions or graft rejection. Both cytokine gene polymorphisms (CGP) and mHA differences resulting on donor-recipient incompatibilities can be jointly assessed in the skin explant assay as a functional way to select the most suitable donor or the best transplant approach for the recipient. In Section III, Dr. Nelson Chao describes non-pharmaceutical techniques to control immune reconstitution post-transplant. T cells stimulated by host alloantigens can be distinguished from resting T cells by the expression of a variety of activation markers (IL-2 receptor, FAS, CD69, CD71) and by an increased photosensitivity to rhodamine dyes. These differences form the basis for eliminating GVHD-reactive T cells in vitro while conserving GVL and anti-viral immunity. Other attempts to control immune reactions post-transplant include the insertion of suicide genes into the transplanted T cells for effective termination of GVHD reactions, the removal of CD62 ligand expressing cells, and the modulation of T cell reactivity by favoring Th2, Tc2 lymphocyte subset expansion. These technologies could eliminate GVHD while preserving T cell responses to leukemia and reactivating viruses.

The aim of this study was to examine the effects of a 7-day Zone diet compared with a normal diet on maximal oxygen uptake (V(O)2 max), running time to exhaustion during endurance performance, and body composition. Eight men, with the following physical characteristics (mean +/- SE), participated in this study: age, 26.1 +/- 1.9 years; height, 178 +/- 1.7 cm; mass, 70.7 +/- 2.1 kg; and V(O)2 max, 54.6 +/- 3.1 ml x kg(-1) x min(-1). All subjects undertook pretesting for V(O)2 max, time to exhaustion (80% V(O)2 max), and body composition (Biostat 1500) before following either the normal diet or the Zone diet for 7 days. These performance trials were performed before and after the dietary period. There was a significant (p < 0.05) decrease in total energy consumption from a mean of 2,314 +/- 334 kcal on a pretest diet to 1,994 +/- 438 kcal on the Zone diet. Subjects showed a significant reduction (p < 0.02) in body mass from 70.7 +/- 2.1 kg to 69.8 +/- 2.1 kg. In the 80% V(O)2 max time to exhaustion trial, there was a significant reduction (p < 0.05) in time to exhaustion from 37.68 +/- 8.6 minutes for the pretest diet to 34.11 +/- 7.01 minutes for the Zone diet. In conclusion, the claim of the authors of the Zone diet that performance time and V(O)2 max can be improved was not shown in this 1-week research trial. We would suggest that this is not a nutritional strategy that athletes should use until further work has been conducted.

This review summarizes recent results investigating the role of certain cytokine gene polymorphisms, including those of TNF-alpha, IFN-gamma, IL-6, IL-10 and IL-1 receptor antagonist (IL-1Ra), in allogeneic stem cell transplantation. It discusses their role in predicting outcome and the development of a genetic risk index for graft versus host disease (GvHD) in HLA-matched sibling transplants. By the comparative use of an in vitro human skin explant model, initial results suggest that certain cytokine gene polymorphisms may be associated with more severe disease.